Litcius/Paper detail

CXCR4-targeted nitric oxide nanoparticles deliver PD-L1 siRNA for immunotherapy against glioblastoma

Hsin-Tzu Hsieh, Hsi‐Chien Huang, Chieh-Wei Chung, Cheng-Chin Chiang, Tiffaney Hsia, Hsin-Fang Wu, Rui-Lin Huang, Chi‐Shiun Chiang, Jane Wang, Tsai‐Te Lu, Yunching Chen

2022Journal of Controlled Release46 citationsDOI

Topics & Concepts

ImmunotherapyCancer researchTumor microenvironmentCXCR4Cytotoxic T cellNitric oxideImmune systemChemistryMedicineImmunologyChemokineTumor cellsInternal medicineIn vitroBiochemistryNanoplatforms for cancer theranosticsRNA Interference and Gene DeliveryImmunotherapy and Immune Responses
CXCR4-targeted nitric oxide nanoparticles deliver PD-L1 siRNA for immunotherapy against glioblastoma | Litcius